ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Sys...
Use this information to figure out if this company is an ideal customer for you.
317.276.2000
50 Imclone Dr
Branchburg, 08876
501 - 1,000 Employees
$1B+
linkedin.com/company/imclone-systems-a-wholly-owned-subsidiary-of-eli-lilly-and-company
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's CEO is Mark Glick
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's CTO is Stephen Kuropchak
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's HQ is located at 50 Imclone Dr, Branchburg
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's phone number is 317.276.2000
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's official website is imclone.com
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company's revenue is $1B+
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company has 501 - 1,000 employees
ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company is in the industry of: Biotechnology
